The Digestive Health Market size was USD 49.46 Billion in 2022 and is expected to Reach USD 94.41 Billion by 2030 and grow at a CAGR of 8.5% over the forecast period of 2023-2030.
The Digestive Health Market refers to the global market for products and services related to the prevention, diagnosis, and treatment of digestive disorders and diseases. Digestive health encompasses the well-being of the digestive system, including the gastrointestinal tract, liver, pancreas, and gallbladder.
Get more information on Digestive Health Market - Request Free Sample Report
The market for digestive health products and services has been growing steadily due to various factors such as the increasing prevalence of digestive disorders, changing dietary patterns, sedentary lifestyles, and a growing aging population. Digestive disorders and diseases include conditions like gastroesophageal reflux disease (GERD), inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), gastrointestinal ulcers, liver diseases, and others.
The Digestive Health Market includes a wide range of products and services such as, Over-the-counter and prescription drugs to treat digestive disorders, including antacids, proton pump inhibitors, laxatives, anti-diarrheal medications, and anti-inflammatory drugs. Probiotics are beneficial bacteria that promote a healthy gut microbiome, while prebiotics are substances that support the growth of beneficial bacteria. They are available in various forms, including supplements, yogurt, and fermented foods. Dietary Supplements such as fiber supplements, enzymes, and herbal products aid digestion and promote digestive health. Diagnostic devices like endoscopes, colonoscopes, and other imaging systems are used for the diagnosis and monitoring of digestive disorders. Functional foods and beverages are fortified with ingredients that promote digestive health, such as fiber, probiotics, and digestive enzymes. Diagnostic services, treatment procedures, and surgical interventions are provided by healthcare facilities and clinics specializing in digestive health.
The market is highly competitive, with both established pharmaceutical companies and emerging startups offering innovative products and services to cater to the growing demand for digestive health solutions. The market is also driven by increasing consumer awareness and a shift towards preventive healthcare, as people recognize the importance of maintaining good digestive health for overall well-being. Gastroesophageal Reflux Disease (GERD) is one of the most prevalent gastrointestinal illnesses, affecting roughly 22% of individuals in Western culture. It is believed that the prevalence of GERD in the United States ranges from 18.4 to 28%. As a result, the necessity for digestive health treatments to control and prevent the causes of developing illnesses is highlighted.
Furthermore, gut health and microbiome have been in demand in the nutraceutical industry for many years, but market growth accelerated during the global pandemic due to consumers' understanding of the connection between digestive health and full body wellbeing, which increased demand and caused the digestive health market size to grow.
DRIVERS:
The world population is aging, which is increasing the frequency of digestive problems. Older people are more vulnerable to illnesses such as acid reflux, constipation, and gastrointestinal malignancies.
Increasing R&D activities by market participants is a positive aspect that will boost growth.
Because of customers' growing awareness about their gut health, the pace of research and development of digestive health products has quickened in recent years. According to a large-scale global research study completed in 2022, more than 45% of individuals worldwide have functional gastrointestinal diseases, which impact quality of life and healthcare use. As a result, individuals are increasingly looking for natural and safe goods.
RESTRAIN:
Long-term usage of some digestive health treatments and pharmaceuticals may result in side effects or safety issues. This may have an influence on market growth.
Strict rules and a revamped tax system are key impediments to market expansion.
Although there are several market growth factors, the digestive health industry is also experiencing certain problems that are limiting growth. One such aspect is the tight standards that vitamin and supplement manufacturers must adhere to prior to product release. The Dietary Supplement Health and Education Act was enacted into law in 1994.
Under this legislation, a company is responsible for ensuring the safety of the dietary supplements it makes or distributes, as well as the accuracy of any statements or claims made about the product.
OPPORTUNITY:
Probiotics and prebiotics have gained significant popularity due to their potential benefits in improving gut health. The market for probiotics and prebiotics is expected to expand further as research continues to uncover their role in maintaining a healthy digestive system.
The growing market for digestive health foods and beverages is a great opportunity.
The market for functional foods and beverages targeted at digestive health is expanding. Consumers are increasingly seeking products that provide both nutrition and digestive benefits. This presents an opportunity for food and beverage companies to develop and market products fortified with ingredients like fiber, probiotics, and digestive enzymes.
CHALLENGES:
public awareness of digestive health is growing, a considerable segment of the population remains unaware of digestive problems, their symptoms, and the significance of obtaining prompt care.
Some digestive problems have few treatment choices, which is a serious hurdle for this sector.
While advances in the treatment of digestive diseases have been made, several ailments still lack specific therapeutic choices. Irritable bowel syndrome (IBS) and functional dyspepsia, for example, can be difficult to manage, and treatment approaches focus on symptom alleviation rather than cure. It is still difficult to develop effective therapies for such illnesses.
We cannot afford to overlook the Russian pharmaceutical industry. Until recently, it was a preferred country in which to conduct clinical trials and register medicinal items or medical devices as a pharmaceutical firm. Aside from practical differences, Russia's situation differs from Ukraine's in that it will have to deal with a tarnished international reputation. It is improbable to predict how protracted it will take to defend. Furthermore, while direct penalties on pharmaceuticals are unlikely to be imposed in the near future, the sanctions will be extremely harmful to Russia's access to healthcare and medications. According to the Russian Pharmaceutical Manufacturers Association, European suppliers have already begun to hinder the transportation of pharmaceutical raw materials to Russian facilities, making following supply contracts very hard to obtain.
When it comes to the pharmaceutical business, Uzbekistan has the highest proportion of imports from Ukraine (6.6% of the country's total pharmaceutical industry imports). Georgia (4.9%) and the Republic of Moldova (4.8%) follow. Uzbekistan (18.8%), Kyrgyzstan (15.2%), and Belarus (13.5%) are the nations that import the most from Russia. Keeping all these data in mind, a decline of 2-3 % can be seen in the import of countries taking raw materials from Ukraine and Russia in the coming time.
Impact of Ongoing Recession
A recession is characterized as a severe drop-in economic activity lasting more than three months. This economic shift has an influence on employment, income, industrial production, and other factors, and the pharmaceutical business is not immune. The unemployment rate in the United States might grow to 4.5% by the end of 2023 and reach 5.2% by 2024. While bigger, more established pharmaceutical firms may have the infrastructure and financial cushion to fall back on, small and medium-sized enterprises (SMEs) must tread cautiously through these economic issues. Companies that rely on angel investors and venture capitalists will be the worst hit by a downturn in the economy.
By Ingredient Type
Digestive Enzymes/Food Enzymes
Probiotics
Others
By Product Type
Vitamins & Dietary Supplements
Functional Foods & Beverages
Others
By Distribution Channel
Hospital Pharmacies
Supermarkets/Hypermarkets
Online Pharmacies
Others
.png)
Need any customization research on Digestive Health Market - Enquiry Now
North America
US
Canada
Mexico
Europe
Eastern Europe
Poland
Romania
Hungary
Turkey
Rest of Eastern Europe
Western Europe
Germany
France
UK
Italy
Spain
Netherlands
Switzerland
Austria
Rest of Western Europe
Asia Pacific
China
India
Japan
South Korea
Vietnam
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
Middle East
UAE
Egypt
Saudi Arabia
Qatar
Rest of Middle East
Africa
Nigeria
South Africa
Rest of Africa
Latin America
Brazil
Argentina
Colombia
Rest of Latin America
North America: North America has a significant share of the Digestive Health Market. The region has a high prevalence of digestive disorders, including GERD, IBD, and IBS. Factors such as a sedentary lifestyle, unhealthy dietary habits, and a growing ageing population contribute to market growth. The presence of a well-established healthcare infrastructure and a strong focus on research and development further drive the market in this region.
Asia Pacific: the Asia Pacific market showed dominance in the market. The key reason driving the region's dominance throughout the projection period is the increased demand for digestive health products in countries such as China, Japan, and India. Furthermore, the increased frequency of digestive issues in the region is another factor driving market expansion in the region.
The major key players in Digestive Health Market are Pfizer Inc., Bayer AG, Herbalife Nutrition Ltd., Sanofi, BASF SE, NOW Health Group Inc., The Bountiful Company, Amway Corporation, Yakult Honsha Co., GlaxoSmithKline PLC, Ltd., and other players.
Megalabs Inc: Megalabs USA, a division of Megalabs Inc, introduced Glutapak R in 2022. The supplement is a probiotic glutamine for intestinal repair and gut health.
Organic India: In 2022, Organic India introduced daily pack supplements. These are portable supplements consisting of whole herb formulae tailored to certain needs such as immunity, mood swings, stress, and digestive and cognitive health.
Wedderspoon: Wedderspoon launched a product range called Manuka Honey Digestive Gummies. The product is available in two formulations: Berry and Tropical. The Tropical gummies contain a special blend of prebiotics, quality ginger and chamomile extracts, and DE111 probiotics. The Berry ones include DE111 probiotics as well as elderberry for immunological and digestive support.
| Report Attributes | Details |
| Market Size in 2022 | US$ 49.16 Bn |
| Market Size by 2030 | US$ 94.41 Bn |
| CAGR | CAGR of 8.5% From 2023 to 2030 |
| Base Year | 2022 |
| Forecast Period | 2023-2030 |
| Historical Data | 2020-2021 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Ingredient Type (Digestive Enzymes/Food Enzymes, Probiotics, Prebiotics, Others) • By Product Type (Vitamins & Dietary Supplements, Functional Foods & Beverages, Others) • By Distribution Channel (Hospital Pharmacies, Supermarkets/Hypermarkets, Online Pharmacies, Others) |
| Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]). Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia Rest of Latin America) |
| Company Profiles | Pfizer Inc., Bayer AG, Herbalife Nutrition Ltd., Sanofi, BASF SE, NOW Health Group Inc., The Bountiful Company, Amway Corporation, Yakult Honsha Co., GlaxoSmithKline PLC, Ltd. |
| Key Drivers | • The world population is ageing, which is increasing the frequency of digestive problems. Older people are more vulnerable to illnesses such as acid reflux, constipation, and gastrointestinal malignancies. • Increasing R&D activities by market participants is a positive aspect that will boost growth. |
| Market Restraints | • Long-term usage of some digestive health treatments and pharmaceuticals may result in side effects or safety issues. This may have an influence on market growth. • Strict rules and a revamped tax system are key impediments to market expansion. |
Ans: Digestive Health Market is expected to grow at a CAGR of 8.6 %.
Ans: Digestive Health Market size was USD 42.01 Billion in 2022 and is expected to Reach USD 81.28 Billion by 2030.
Ans: The functional foods and drinks sector will dominate the market in terms of product type.
Ans: The rising prevalence of digestive issues, greater awareness, an ageing population, and an increased willingness to spend on gut health are the primary drivers of market expansion.
Ans: The digestive system is vital to your general health because it transports nutrients to your body. Without appropriate digestive health, you may suffer from a variety of unpleasant symptoms such as stomach discomfort, bloating, indigestion, and others.
Table of Contents
1. Introduction
1.1 Market Definition
1.2 Scope
1.3 Research Assumptions
2. Research Methodology
3. Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges
4. Impact Analysis
4.1 Impact of Russia-Ukraine War
4.2 Impact of Ongoing Recession
4.2.1 Introduction
4.2.2 Impact on major economies
4.2.2.1 US
4.2.2.2 Canada
4.2.2.3 Germany
4.2.2.4 France
4.2.2.5 United Kingdom
4.2.2.6 China
4.2.2.7 Japan
4.2.2.8 South Korea
4.2.2.9 Rest of the World
4.3 Supply Demand Gap Analysis
5. Value Chain Analysis
6. Porter’s 5 forces model
7. PEST Analysis
8. Digestive Health Market Segmentation, By Ingredient Type
8.1 Digestive Enzymes/Food Enzymes
8.2 Probiotics
8.3 Prebiotics
8.4 Others
9. Digestive Health Market Segmentation, By Product Type
9.1 Vitamins & Dietary Supplements
9.2 Functional Foods & Beverages
9.3 Others
10. Digestive Health Market Segmentation, By Distribution Channel
10.1 Hospital Pharmacies
10.2 Supermarkets/Hypermarkets
10.3 Online Pharmacies
10.4 Others
11. Regional Analysis
11.1 Introduction
11.2 North America
11.2.1 North America Digestive Health Market by Country
11.2.2 North America Digestive Health Market by Ingredient Type
11.2.3 North America Digestive Health Market by Product Type
11.2.4 North America Digestive Health Market by Distribution Channel
11.2.5 USA
11.2.5.1 USA Digestive Health Market by Ingredient Type
11.2.5.2 USA Digestive Health Market by Product Type
11.2.5.3 USA Digestive Health Market by Distribution Channel
11.2.6 Canada
11.2.6.1 Canada Digestive Health Market by Ingredient Type
11.2.6.2 Canada Digestive Health Market by Product Type
11.2.6.3 Canada Digestive Health Market by Distribution Channel
11.2.7 Mexico
11.2.7.1 Mexico Digestive Health Market by Ingredient Type
11.2.7.2 Mexico Digestive Health Market by Product Type
11.2.7.3 Mexico Digestive Health Market by Distribution Channel
11.3 Europe
11.3.1 Eastern Europe
11.3.1.1 Eastern Europe Digestive Health Market by Country
11.3.1.2 Eastern Europe Digestive Health Market by Ingredient Type
11.3.1.3 Eastern Europe Digestive Health Market by Product Type
11.3.1.4 Eastern Europe Digestive Health Market by Distribution Channel
11.3.1.5 Poland
11.3.1.5.1 Poland Digestive Health Market by Ingredient Type
11.3.1.5.2 Poland Digestive Health Market by Product Type
11.3.1.5.3 Poland Digestive Health Market by Distribution Channel
11.3.1.6 Romania
11.3.1.6.1 Romania Digestive Health Market by Ingredient Type
11.3.1.6.2 Romania Digestive Health Market by Product Type
11.3.1.6.4 Romania Digestive Health Market by Distribution Channel
11.3.1.7 Turkey
11.3.1.7.1 Turkey Digestive Health Market by Ingredient Type
11.3.1.7.2 Turkey Digestive Health Market by Product Type
11.3.1.7.3 Turkey Digestive Health Market by Distribution Channel
11.3.1.8 Rest of Eastern Europe
11.3.1.8.1 Rest of Eastern Europe Digestive Health Market by Ingredient Type
11.3.1.8.2 Rest of Eastern Europe Digestive Health Market by Product Type
11.3.1.8.3 Rest of Eastern Europe Digestive Health Market by Distribution Channel
11.3.2 Western Europe
11.3.2.1 Western Europe Digestive Health Market by Country
11.3.2.2 Western Europe Digestive Health Market by Ingredient Type
11.3.2.3 Western Europe Digestive Health Market by Product Type
11.3.2.4 Western Europe Digestive Health Market by Distribution Channel
11.3.2.5 Germany
11.3.2.5.1 Germany Digestive Health Market by Ingredient Type
11.3.2.5.2 Germany Digestive Health Market by Product Type
11.3.2.5.3 Germany Digestive Health Market by Distribution Channel
11.3.2.6 France
11.3.2.6.1 France Digestive Health Market by Ingredient Type
11.3.2.6.2 France Digestive Health Market by Product Type
11.3.2.6.3 France Digestive Health Market by Distribution Channel
11.3.2.7 UK
11.3.2.7.1 UK Digestive Health Market by Ingredient Type
11.3.2.7.2 UK Digestive Health Market by Product Type
11.3.2.7.3 UK Digestive Health Market by Distribution Channel
11.3.2.8 Italy
11.3.2.8.1 Italy Digestive Health Market by Ingredient Type
11.3.2.8.2 Italy Digestive Health Market by Product Type
11.3.2.8.3 Italy Digestive Health Market by Distribution Channel
11.3.2.9 Spain
11.3.2.9.1 Spain Digestive Health Market by Ingredient Type
11.3.2.9.2 Spain Digestive Health Market by Product Type
11.3.2.9.3 Spain Digestive Health Market by Distribution Channel
11.3.2.10 Netherlands
11.3.2.10.1 Netherlands Digestive Health Market by Ingredient Type
11.3.2.10.2 Netherlands Digestive Health Market by Product Type
11.3.2.10.3 Netherlands Digestive Health Market by Distribution Channel
11.3.2.11 Switzerland
11.3.2.11.1 Switzerland Digestive Health Market by Ingredient Type
11.3.2.11.2 Switzerland Digestive Health Market by Product Type
11.3.2.11.3 Switzerland Digestive Health Market by Distribution Channel
11.3.2.1.12 Austria
11.3.2.12.1 Austria Digestive Health Market by Ingredient Type
11.3.2.12.2 Austria Digestive Health Market by Product Type
11.3.2.12.3 Austria Digestive Health Market by Distribution Channel
11.3.2.13 Rest of Western Europe
11.3.2.13.1 Rest of Western Europe Digestive Health Market by Ingredient Type
11.3.2.13.2 Rest of Western Europe Digestive Health Market by Product Type
11.3.2.13.3 Rest of Western Europe Digestive Health Market by Distribution Channel
11.4 Asia-Pacific
11.4.1 Asia-Pacific Digestive Health Market by Country
11.4.2 Asia-Pacific Digestive Health Market by Ingredient Type
11.4.3 Asia-Pacific Digestive Health Market by Product Type
11.4.4 Asia-Pacific Digestive Health Market by Distribution Channel
11.4.5 China
11.4.5.1 China Digestive Health Market by Ingredient Type
11.4.5.2 China Digestive Health Market by Distribution Channel
11.4.5.3 China Digestive Health Market by Product Type
11.4.6 India
11.4.6.1 India Digestive Health Market by Ingredient Type
11.4.6.2 India Digestive Health Market by Product Type
11.4.6.3 India Digestive Health Market by Distribution Channel
11.4.7 japan
11.4.7.1 Japan Digestive Health Market by Ingredient Type
11.4.7.2 Japan Digestive Health Market by Product Type
11.4.7.3 Japan Digestive Health Market by Distribution Channel
11.4.8 South Korea
11.4.8.1 South Korea Digestive Health Market by Ingredient Type
11.4.8.2 South Korea Digestive Health Market by Product Type
11.4.8.3 South Korea Digestive Health Market by Distribution Channel
11.4.9 Vietnam
11.4.9.1 Vietnam Digestive Health Market by Ingredient Type
11.4.9.2 Vietnam Digestive Health Market by Product Type
11.4.9.3 Vietnam Digestive Health Market by Distribution Channel
11.4.10 Singapore
11.4.10.1 Singapore Digestive Health Market by Ingredient Type
11.4.10.2 Singapore Digestive Health Market by Product Type
11.4.10.3 Singapore Digestive Health Market by Distribution Channel
11.4.11 Australia
11.4.11.1 Australia Digestive Health Market by Ingredient Type
11.4.11.2 Australia Digestive Health Market by Product Type
11.4.11.3 Australia Digestive Health Market by Distribution Channel
11.4.12 Rest of Asia-Pacific
11.4.12.1 Rest of Asia-Pacific Digestive Health Market by Ingredient Type
11.4.12.2 Rest of Asia-Pacific Digestive Health Market by Product Type
11.4.12.3 Rest of Asia-Pacific Digestive Health Market by Distribution Channel
11.5 Middle East & Africa
11.5.1 Middle East
11.5.1.1 Middle East Digestive Health Market by Country
11.5.1.2 Middle East Digestive Health Market by Ingredient Type
11.5.1.3 Middle East Digestive Health Market by Product Type
11.5.1.4 Middle East Digestive Health Market by Distribution Channel
11.5.1.5 UAE
11.5.1.5.1 UAE Digestive Health Market by Ingredient Type
11.5.1.5.2 UAE Digestive Health Market by Product Type
11.5.1.5.3 UAE Digestive Health Market by Distribution Channel
11.5.1.6 Egypt
11.5.1.6.1 Egypt Digestive Health Market by Ingredient Type
11.5.1.6.2 Egypt Digestive Health Market by Product Type
11.5.1.6.3 Egypt Digestive Health Market by Distribution Channel
11.5.1.7 Saudi Arabia
11.5.1.7.1 Saudi Arabia Digestive Health Market by Ingredient Type
11.5.1.7.2 Saudi Arabia Digestive Health Market by Product Type
11.5.1.7.3 Saudi Arabia Digestive Health Market by Distribution Channel
11.5.1.8 Qatar
11.5.1.8.1 Qatar Digestive Health Market by Ingredient Type
11.5.1.8.2 Qatar Digestive Health Market by Product Type
11.5.1.8.3 Qatar Digestive Health Market by Distribution Channel
11.5.1.9 Rest of Middle East
11.5.1.9.1 Rest of Middle East Digestive Health Market by Ingredient Type
11.5.1.9.2 Rest of Middle East Digestive Health Market by Product Type
11.5.1.9.3 Rest of Middle East Digestive Health Market by Distribution Channel
11.5.2 Africa
11.5.2.1 Africa Transfusion Diagnostics Market by Country
11.5.2.2 Africa Digestive Health Market by Ingredient Type
11.5.2.3 Africa Digestive Health Market by Product Type
11.5.2.4 Africa Digestive Health Market by Distribution Channel
11.5.2.5 Nigeria
11.5.2.5.1 Nigeria Digestive Health Market by Ingredient Type
11.5.2.5.2 Nigeria Digestive Health Market by Product Type
11.5.2.5.3 Nigeria Digestive Health Market by Distribution Channel
11.5.2.6 South Africa
11.5.2.6.1 South Africa Digestive Health Market by Ingredient Type
11.5.2.6.2 South Africa Digestive Health Market by Product Type
11.5.2.6.3 South Africa Digestive Health Market by Distribution Channel
11.5.2.7 Rest of Africa
11.5.2.7.1 Rest of Africa Digestive Health Market by Ingredient Type
11.5.2.7.2 Rest of Africa Digestive Health Market by Product Type
11.5.2.7.3 Rest of Africa Digestive Health Market by Distribution Channel
11.6 Latin America
11.6.1 Latin America Digestive Health Market by Country
11.6.2 Latin America Digestive Health Market by Ingredient Type
11.6.3 Latin America Digestive Health Market by Product Type
11.6.4 Latin America Digestive Health Market by Distribution Channel
11.6.5 Brazil
11.6.5.1 Brazil America Digestive Health Market by Ingredient Type
11.6.5.2 Brazil America Digestive Health Market by Product Type
11.6.5.3 Brazil America Digestive Health Market by Distribution Channel
11.6.6 Argentina
11.6.6.1 Argentina America Digestive Health Market by Ingredient Type
11.6.6.2 Argentina America Digestive Health Market by Product Type
11.6.6.3 Argentina America Digestive Health Market by Distribution Channel
11.6.7 Colombia
11.6.7.1 Colombia America Digestive Health Market by Ingredient Type
11.6.7.2 Colombia America Digestive Health Market by Product Type
11.6.7.3 Colombia America Digestive Health Market by Distribution Channel
11.6.8 Rest of Latin America
11.6.8.1 Rest of Latin America Digestive Health Market by Ingredient Type
11.6.8.2 Rest of Latin America Digestive Health Market by Product Type
11.6.8.3 Rest of Latin America Digestive Health Market by Distribution Channel
12 Company profile
12.1 Pfizer Inc
12.1.1 Company Overview
12.1.2 Financials
12.1.3 Product/Services Offered
12.1.4 SWOT Analysis
12.1.5 The SNS View
12.2 Bayer AG
12.2.1 Company Overview
12.2.2 Financials
12.2.3 Product/Services Offered
12.2.4 SWOT Analysis
12.2.5 The SNS View
12.3 Herbalife Nutrition Ltd.
12.3.1 Company Overview
12.3.2 Financials
12.3.3 Product/Services Offered
12.3.4 SWOT Analysis
12.3.5 The SNS View
12.4 Sanofi
12.4.1 Company Overview
12.4.2 Financials
12.4.3 Product/Services Offered
12.4.4 SWOT Analysis
12.4.5 The SNS View
12.5 BASF SE
12.5.1 Company Overview
12.5.2 Financials
12.5.3 Product/Services Offered
12.5.4 SWOT Analysis
12.5.5 The SNS View
12.6 NOW Health Group Inc
12.6.1 Company Overview
12.6.2 Financials
12.6.3 Product/Services Offered
12.6.4 SWOT Analysis
12.6.5 The SNS View
12.7 The Bountiful Company
12.7.1 Company Overview
12.7.2 Financials
12.7.3 Product/Services Offered
12.7.4 SWOT Analysis
12.7.5 The SNS View
12.8 Amway Corporation
12.8.1 Company Overview
12.8.2 Financials
12.8.3 Product/Services Offered
12.8.4 SWOT Analysis
12.8.5 The SNS View
12.9 Yakult Honsha Co
12.9.1 Company Overview
12.9.2 Financials
12.9.3 Product/Services Offered
12.9.4 SWOT Analysis
12.9.5 The SNS View
12.10 GlaxoSmithKline PLC, Ltd
12.10.1 Company Overview
12.10.2 Financials
12.10.3 Product/Services Offered
12.10.4 SWOT Analysis
12.10.5 The SNS View
13. Competitive Landscape
13.1 Competitive Benchmarking
13.2 Market Share Analysis
13.3 Recent Developments
13.3.1 Industry News
13.3.2 Company News
13.3.3 Mergers & Acquisitions
14. Use Case and Best Practices
15. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
The Cosmeceutical Market size was valued USD 56.80 billion in 2022 and is expected to reach USD 114.34 billion by 2030 and grow at a CAGR of 8.9% over the forecast period of 2023-2030.
The Point of Care Lipid Test Market size was estimated USD 41.33 billion in 2023 and is expected to reach USD 69.96 billion by 2031 at a CAGR of 6.8% during the forecast period of 2024-2031.
In 2023, The Telerehabilitation Market size amounted to USD 4.90 Billion & is estimated to reach USD 13.60 Billion by 2031 and increase at a compound annual growth rate of 13.6% between 2024 and 2031.
The Drug Eluting Stent Market size was estimated USD 2897.6 million in 2022 and is expected to reach USD 4795.51million by 2030 at a CAGR of 6.5% during the forecast period of 2023-2030.
The Defibrillator Market size was estimated at USD 7.07 billion in 2023 and is expected to reach USD 13.98 billion by 2031 at a CAGR of 8.71% during the forecast period of 2024-2031.
The Neuroendoscopy Market size is projected to grow from $151.07 million in 2023 to $237.05 million by 2031, at a CAGR of 5.8% during the forecast period.
Hi! Click one of our member below to chat on Phone
© 2024 All Rights Reserved by SNS Insider Pvt Ltd
